Precidex and Cis-Curon – Celebrating First Successful Year

July 8, 2019

Anaesthesia is a critical area of medicine. The practice of anaesthesia has now evolved to the point that it is among the safest of all major routine medical procedures. A wide variety of drugs are used in modern anesthetic practices.

Brookes Pharma has been pioneered to bring innovative anaesthesia molecules in Pakistan. Keeping the legacy Brookes has introduced two novel New Chemical Entities (NCE), (Cisatracurium) Cis-Curon and (Dexmedetomidine) Precidex Injections first time in Pakistan pharmaceutical market.

Cis-Curon (Cisatracurium) has break all the records of Brookes history and become the first product ever to reach the highest mark in the first year of launch, and Precidex (Dexmedetomidine) also secured a sound position in its first year.

The successful first year was celebrated by the Management, Technical, Operational and Marketing Heads on a cake cutting ceremony where the occasion was graced by honorable CEO of Brookes Pharma.